Breaking News Instant updates and real-time market news.

IMGN

ImmunoGen

$5.59

0.13 (2.38%)

16:36
01/11/19
01/11
16:36
01/11/19
16:36

Morgan Stanley reports 5.3% passive stake in ImmunoGen

In a regulatory filing, Morgan Stanley disclosed a 5.3% stake in ImmunoGen, which represents about 8M shares. The filing does not allow for activism.

IMGN ImmunoGen
$5.59

0.13 (2.38%)

09/17/18
GUGG
09/17/18
INITIATION
GUGG
Guggenheim calls Array, Deciphera, ImmunoGen top biotech picks
Guggenheim initiated coverage of the biotechnology sector, initiating and assuming coverage of 17 biotechnology stocks, and saying it is bullish on the sector longer term and expects continued growth. The firm's coverage focuses on the oncology therapeutic category, with Guggenheim calling Array Biopharma (ARRY), Deciphera Pharmaceuticals (DCPH), and ImmunoGen (IMGN), which all have key catalysts coming in the first half or 2019, its top picks.
11/01/18
PIPR
11/01/18
NO CHANGE
Target $15
PIPR
Overweight
ImmunoGen data give 'very positive' first look at IMGN632, says Piper Jaffray
Piper Jaffray analyst Joseph Catanzaro said the abstract for IMGN632 to be presented by ImmunoGen at the ASH meeting on its Phase 1 trial of IMGN632 in relapsed/refractory acute myeloid leukemia gives a "very positive first look," though he adds that he views the program as carrying significant clinical risk given the novel payload and prior failure of a similar drug. Catanzaro has an Overweight rating and $15 price target on ImmunoGen shares.
11/27/18
HCWC
11/27/18
NO CHANGE
HCWC
Buy
ImmunoGen CFO resignation not based on current role, says H.C. Wainwright
H.C. Wainwright analyst Debjit Chattopadhyay says the resignation of ImmunoGen (IMGN) CFO David Johnston after the executive was found guilty for civil securities fraud has little to do with the execution of his current responsibilities, but a reflection of his tenure with Aveo Pharmaceuticals (AVEO) pharmaceuticals between 2007 and 2012. Given that a potential guilty verdict was always a possibility, the analyst anticipates a potential replacement "in the not so distant future." With ImmunoGen having made "significant strides" over the past five years, and now closer to commercialization with mirvetuximab Phase 3 readout anticipated during the first half of 2019, any potential replacement might come with prior oncology commercialization experience, and might be a better fit with future needs of the company, Chattopadhyay tells investors in a research note titled "Water Under the old AVEO Bridge." He admits, however, that the resignation is publicity ImmunoGen "could have done without." Chattopadhyay keeps a Buy rating on ImmunoGen with an $18 price target.
12/02/18
PIPR
12/02/18
NO CHANGE
Target $14
PIPR
Overweight
'Solid' early single agent activity for ImmunoGen '632, says Piper Jaffray
Piper Jaffray analyst Joseph Catanzaro notes that ImmunoGen presented updates from the Phase I trials of both IMGN632 and IMGN779in r/r AML and BPDCN at ASH this weekend. While the aanalyst acknowledges that some may be disappointed with the slight dip in CR/CRi rate for '632 and the lack of dose response, he finds the clear anti-leukemic activity at the lower, more tolerable doses notable and sees this as a positive first full look for this program. '779 still looks to be struggling to find an active dose, Catanzarro contends, adding that he is unsure whether higher doses will elicit enough of an increase in activity without increased toxicity that would warrant further monotherapy development. He reiterates an Overweight rating and $14 price target on the shares.

TODAY'S FREE FLY STORIES

PLWTY

Panalpina

$0.00

(0.00%)

08:44
01/21/19
01/21
08:44
01/21/19
08:44
Downgrade
Panalpina rating change  »

Panalpina downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EFGSY

Eiffage

$0.00

(0.00%)

08:41
01/21/19
01/21
08:41
01/21/19
08:41
Upgrade
Eiffage rating change  »

Eiffage upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TVFCF

Television Francaise 1

$0.00

(0.00%)

08:40
01/21/19
01/21
08:40
01/21/19
08:40
Downgrade
Television Francaise 1 rating change  »

Television Francaise 1…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ATVDY

Atresmedia

$0.00

(0.00%)

08:37
01/21/19
01/21
08:37
01/21/19
08:37
Upgrade
Atresmedia rating change  »

Atresmedia upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TDPAY

Tod's

$0.00

(0.00%)

08:36
01/21/19
01/21
08:36
01/21/19
08:36
Downgrade
Tod's rating change  »

Tod's downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SFRGY

Salvatore Ferragamo

$0.00

(0.00%)

08:35
01/21/19
01/21
08:35
01/21/19
08:35
Downgrade
Salvatore Ferragamo rating change  »

Salvatore Ferragamo…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

08:35
01/21/19
01/21
08:35
01/21/19
08:35
General news
FX Action: USD-CAD has nudged back above 1.3300 »

FX Action: USD-CAD has…

PRDSY

Prada

$0.00

(0.00%)

08:34
01/21/19
01/21
08:34
01/21/19
08:34
Upgrade
Prada rating change  »

Prada upgraded to Neutral…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PANDY

Pandora A/S

$0.00

(0.00%)

08:33
01/21/19
01/21
08:33
01/21/19
08:33
Downgrade
Pandora A/S rating change  »

Pandora A/S downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SLGGF

SolGold

$0.00

(0.00%)

08:32
01/21/19
01/21
08:32
01/21/19
08:32
Initiation
SolGold initiated  »

SolGold initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PCFBY

Pacific Basin Shipping

$0.00

(0.00%)

08:30
01/21/19
01/21
08:30
01/21/19
08:30
Upgrade
Pacific Basin Shipping rating change  »

Pacific Basin Shipping…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

08:30
01/21/19
01/21
08:30
01/21/19
08:30
General news
Oil Action: Front-month WTI futures are near flat »

Oil Action: Front-month…

WFAFY

Wesfarmers

$0.00

(0.00%)

08:27
01/21/19
01/21
08:27
01/21/19
08:27
Downgrade
Wesfarmers rating change  »

Wesfarmers downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RTOKY

Rentokil

$0.00

(0.00%)

08:26
01/21/19
01/21
08:26
01/21/19
08:26
Downgrade
Rentokil rating change  »

Rentokil downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BNTGY

Brenntag

$0.00

(0.00%)

08:25
01/21/19
01/21
08:25
01/21/19
08:25
Upgrade
Brenntag rating change  »

Brenntag upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

08:25
01/21/19
01/21
08:25
01/21/19
08:25
General news
Oil Action: Front-month WTI futures are near flat »

Oil Action: Front-month…

LOIMF

Loomis AB

$0.00

(0.00%)

08:24
01/21/19
01/21
08:24
01/21/19
08:24
Downgrade
Loomis AB rating change  »

Loomis AB downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SFTBY

SoftBank; also use SFTBF

$0.00

(0.00%)

08:21
01/21/19
01/21
08:21
01/21/19
08:21
Initiation
SoftBank; also use SFTBF initiated  »

SoftBank initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

07:00
01/21/19
01/21
07:00
01/21/19
07:00
General news
FX Update: There hasn't been a strong theme »

FX Update: There…

CYDY

CytoDyn

$0.00

(0.00%)

04:55
01/21/19
01/21
04:55
01/21/19
04:55
Conference/Events
CytoDyn participates in lunch meeting with Philadelphia Securities »

Luncheon Meeting with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jan

03:45
01/21/19
01/21
03:45
01/21/19
03:45
General news
FX Action: USD-CAD has settled back in the upper 1.3200s »

FX Action: USD-CAD has…

03:05
01/21/19
01/21
03:05
01/21/19
03:05
General news
FX Update: The Dollar majors have been trading with little directional bias »

FX Update: The Dollar…

MET

MetLife

$45.32

0.28 (0.62%)

19:55
01/20/19
01/20
19:55
01/20/19
19:55
Hot Stocks
MetLife announces Richard Nunn as new CEO for Australia »

MetLife announced Richard…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Feb

  • 18

    Jun

AMZN

Amazon.com

$1,696.01

4.01 (0.24%)

, TSLA

Tesla

$302.26

-45.18 (-13.00%)

19:27
01/20/19
01/20
19:27
01/20/19
19:27
Hot Stocks
Fly Intel: Top five weekend stock stories »

Catch up on the…

AMZN

Amazon.com

$1,696.01

4.01 (0.24%)

TSLA

Tesla

$302.26

-45.18 (-13.00%)

NFLX

Netflix

$339.20

-14.02 (-3.97%)

EA

Electronic Arts

$92.50

3.19 (3.57%)

ATVI

Activision Blizzard

$48.64

1.26 (2.66%)

CMCSA

Comcast

$36.21

0.32 (0.89%)

CMCSK

Comcast

$0.00

(0.00%)

COST

Costco

$213.59

2.15 (1.02%)

ILMN

Illumina

$312.66

2.53 (0.82%)

TMO

Thermo Fisher

$240.72

2.55 (1.07%)

DHR

Danaher

$107.43

1.88 (1.78%)

A

Agilent

$71.93

1.16 (1.64%)

TECH

Bio-Techne

$163.24

1.16 (0.72%)

NEM

Newmont Mining

$31.77

0.15 (0.47%)

GOLD

Barrick Gold

$11.78

-0.11 (-0.93%)

KRC

Kilroy Realty

$68.23

0.21 (0.31%)

VNO

Vornado

$66.40

1.04 (1.59%)

TCEHY

Tencent

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 23

    Jan

  • 24

    Jan

  • 24

    Jan

  • 28

    Jan

  • 29

    Jan

  • 29

    Jan

  • 30

    Jan

  • 30

    Jan

  • 31

    Jan

  • 05

    Feb

  • 05

    Feb

  • 05

    Feb

  • 12

    Feb

  • 20

    Feb

  • 21

    Feb

  • 25

    Feb

  • 03

    Mar

NTDOY

Nintendo

$0.00

(0.00%)

17:55
01/20/19
01/20
17:55
01/20/19
17:55
Periodicals
Nintendo investors starting to feel optimistic again, Bloomberg says »

Nintendo investors,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.